Literature DB >> 13677482

Superimposition evaluation of ecdysteroid agonist chemotypes through multidimensional QSAR.

Robert E Hormann1, Laurence Dinan, Pensri Whiting.   

Abstract

The EC50 values for a training set of 66 ecdysteroids and 97 diacylhydrazines were measured in the ecdysteroid-responsive Drosophila melanogaster BII cell line, a prototypical homologous inducible gene expression system. Each of eight superimposition hypotheses for the folded diacylhydrazine conformation was evaluated and ranked on the basis of CoMFA and 4D-QSAR Q2 values for the training set and R2 values for a 52-member test set comprising randomly-chosen diacylhydrazines and chronologically-chosen ecdysteroids for which data became available after model construction. Both 4D-QSAR and CoMFA rate a common superimposition as the preferred one. Two additional superimpositions, with somewhat weaker 4D-QSAR and CoMFA consensus, nonetheless share several important topological features. The resultant QSAR models address the question of relative binding orientation of the two ligand families and can be useful as a virtual screen for new chemotypes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13677482     DOI: 10.1023/a:1025365722403

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  23 in total

1.  An extensive ecdysteroid CoMFA.

Authors:  L Dinan; R E Hormann; T Fujimoto
Journal:  J Comput Aided Mol Des       Date:  1999-03       Impact factor: 3.686

Review 2.  Gene therapy of human disease.

Authors:  Danuta Balicki; Ernest Beutler
Journal:  Medicine (Baltimore)       Date:  2002-01       Impact factor: 1.889

3.  4D-QSAR analysis of a set of ecdysteroids and a comparison to CoMFA modeling.

Authors:  M Ravi; A J Hopfinger; R E Hormann; L Dinan
Journal:  J Chem Inf Comput Sci       Date:  2001 Nov-Dec

Review 4.  Critical issues in gene therapy for neurologic disease.

Authors:  Gary Hsich; Miguel Sena-Esteves; Xandra O Breakefield
Journal:  Hum Gene Ther       Date:  2002-03-20       Impact factor: 5.695

5.  Ecdysone-inducible gene expression in mammalian cells and transgenic mice.

Authors:  D No; T P Yao; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

6.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

7.  A genetic algorithm for flexible molecular overlay and pharmacophore elucidation.

Authors:  G Jones; P Willett; R C Glen
Journal:  J Comput Aided Mol Des       Date:  1995-12       Impact factor: 3.686

8.  Molting hormonal and larvicidal activities of aliphatic acyl analogs of dibenzoylhydrazine insecticides.

Authors:  B Shimizu; Y Nakagawa; K Hattori; K Nishimura; N Kurihara; T Ueno
Journal:  Steroids       Date:  1997-10       Impact factor: 2.668

9.  Identification of ligands and coligands for the ecdysone-regulated gene switch.

Authors:  E Saez; M C Nelson; B Eshelman; E Banayo; A Koder; G J Cho; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

10.  The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.

Authors:  A K Shiau; D Barstad; P M Loria; L Cheng; P J Kushner; D A Agard; G L Greene
Journal:  Cell       Date:  1998-12-23       Impact factor: 41.582

View more
  2 in total

1.  Nonsteroidal ecdysone receptor agonists use a water channel for binding to the ecdysone receptor complex EcR/USP.

Authors:  Christopher Browning; Alastair G McEwen; Kotaro Mori; Taiyo Yokoi; Dino Moras; Yoshiaki Nakagawa; Isabelle M L Billas
Journal:  J Pestic Sci       Date:  2021-02-20       Impact factor: 2.529

Review 2.  Two Decades of 4D-QSAR: A Dying Art or Staging a Comeback?

Authors:  Andrzej Bak
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.